Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for prevention of vancomycin-induced nephrotoxicity
IRCT20200408046990N18Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in nephrotoxicity, sponsored by Mashhad University of Medical Sciences. Started Jun 2025; status: recruiting.
02
Drugs
melatonin
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on IRCT20200408046990N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200408046990N18.